Magdalena Dudzińska

Magdalena Dudzińska

Auto-generated profile, based on publicly available information

Magdalena Dudzińska

Pediatric Neurology Department, Chorzow General Hospital, 41-500 Chorzów, Poland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
MCMarcin Chyra
Marcin Chyra
WRWojciech Roczniak
Wojciech Roczniak
EŚElżbieta Świętochowska
Elżbieta Świętochowska
MDMagdalena Dudzińska
Magdalena Dudzińska
JOJoanna Oswiecimska
Joanna Oswiecimska
Background: Changes in adipokine secretion may be involved in the anti-epileptic effect of a ketogenic diet (KD) in drug-resistant epilepsy (DRE). Objectives: The assessment of the influence of KD on serum adiponectin, omentin-1, and vaspin in children with DRE. Methods: Anthropometric measurements (weight, height, BMI, and waist-to-hip circumference ratio) were performed in 72 children aged 3–9 years, divided into 3 groups: 24 children with DRE treated with KD, 26—treated with valproic acid (VPA), and a control group of 22 children. Biochemical tests included fasting glucose, insulin, beta-hydroxybutyric acid, lipid profile, aminotransferases activities, and blood gasometry. Serum levels of adiponectin, omentin-1 and vaspin were assayed using commercially available ELISA tests. Results: Serum levels of adiponectin and omentin-1 in the KD group were significantly higher and vaspin—lower in comparison to patients receiving VPA and the control group. In all examined children, serum adiponectin and omentin-1 correlated negatively with WHR and serum triglycerides, insulin, fasting glucose, and HOMA-IR. Vaspin levels correlated negatively with serum triglycerides and positively with body weight, BMI, fasting glucose, insulin, and HOMA-IR. Conclusion: One of the potential mechanisms of KD in children with drug-resistant epilepsy may be a modulation of metabolically beneficial and anti-inflammatory adipokine levels.

17 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
WBWaldemar Brola
Waldemar Brola
BSBarbara Steinborn
Barbara Steinborn
Marek ZakMarek Zak
Marek Zak
MMMaria Mazurkiewicz-Bełdzińska
Maria Mazurkiewicz-Bełdzińska
Sergiusz JóźwiakSergiusz Jóźwiak
Sergiusz Jóźwiak
KKKatarzyna Kotulska-Jóźwiak
Katarzyna Kotulska-Jóźwiak
Background. Paediatric-onset MS (POMS) has a unique clinical profile compared to the more prevalent adult-onset MS. For this study, we aimed to determine the demographic and clinical characteristics of POMS in Poland as well as addressing some of its epidemiological aspects. Methods. A retrospective study was conducted based on the Polish Multiple Sclerosis Registry, considering a population of children and adolescents with MS (age ≤ 18 years). Data were collected by all 13 centres across Poland specializing in diagnosing and treating POMS. The actual course of the disease and its clinical properties were compared between child (≤12 years) and juvenile (>12 years) patients. MS onset and its prevalence were assessed at the end of 2019, stratified by age range. Results. A total of 329 paediatric or juvenile patients (228 girls, 101 boys) with a clinically definite diagnosis of MS, in conformity with the 2017 McDonald Criteria, were enrolled. For 71 children (21.6%), the first symptoms appeared before the age of 12. The female: male ratio increased with age, amounting to 1:1 in the ≤12 years group and to 2.9:1 in the >12 years group. In most cases, the disease had multi-symptomatic onset (31.3%), and its course was mostly of a relapsing–remitting character (95.7%). The initial Expanded Disability Status Score for both groups was 1.63 ± 1.1, whereas the annual relapse rate was 0.84 during the first 2 years. The time between the onset of symptoms and diagnosis was longer in the younger patients (8.2 ± 4.2 vs. 4.6 ± 3.6 months; p < 0.005). On 31 December 2019, the age-adjusted prevalence standardized to the European standard population was 5.19/100,000 (95% CI, 4.64–5.78). Significantly higher prevalence was noted in the 13–18 years group (7.12; 95% CI, 6.64–7.86) than in the 9–12 years group (3.41; 95% CI, 2.98–3.86) and the <9 years group (0.56; 95% CI, 0.46–0.64; p < 0.001). Conclusion. POMS commencing at the age of ≤12 years is rare, differing significantly from the juvenile-onset and adult MS in terms of clinical characteristics, course, and incidence, as stratified by gender.

21 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Katarzyna Magdalena KowalczeKatarzyna Magdalena Kowalcze
Katarzyna Magdalena Kowalcze
DDDamian Dyńka
Damian Dyńka
WKWiktoria Klus
Wiktoria Klus
MDMagdalena Dudzińska
Magdalena Dudzińska
APAgnieszka Paziewska
Agnieszka Paziewska
Background/Objectives: The over 100-year-old practice of using ketogenic diet (KD) in the treatment of epilepsy has consolidated its position as an effective therapeutic tool. The available publications suggest a significant influence of KD on gut microbiome and metabolome and, on the other hand, a correlation between microbiome and metabolome changes and the course of epilepsy. The conclusion is therefore justified that KD can exert a therapeutic effect in epilepsy through the mechanism of gut microbiome and metabolome modulation. Methods:This article is a narrative review aimed at a comprehensive analysis of the literature to gather existing evidence on the relationship between ketogenic diet, its antiepileptic effects and modulation of gut microbiome and metabolome. Results: It has been demonstrated that a ketogenic diet exerts a significant effect on intestinal bacteria and their metabolites, among other actions, increasing the Bacteroides to Firmicutes (B/F) ratio, alleviating dysbiosis, reducing the inflammatory condition in the gut and whole body, increasing the number of specific strains associated with antiepileptic effect, mediating the production of neurotransmitters (GABA, serotonin), exerting influence on the dopaminergic system, on a number of metabolic pathways, on inhibition of genotoxicity and production of short-chain fatty acids (SCFA) in the intestine. Conclusions: Further studies are needed, since the effect of KD on gut microbiome and metabolome modulation in the treatment of epilepsy is an extremely promising and trendsetting direction of research.

27 August 2018 in Journal of Epileptology
Verified
Journal Article
Open access
PDF file
MDMagdalena Dudzińska
Magdalena Dudzińska
Finding an effective epilepsy treatment has been a challenge in medicine for centuries. It is especially difficult to treat drug-resistant epilepsy, which accounts for 20–30% of epilepsy cases, even after the introduction of numerous new anti-epileptic drugs (AEDs). This gives an incentive to search for therapies other than pharmacotherapy, e.g. the ketogenic diet (KD).

1 January 2018 in Child Neurology
Verified
Journal Article
Open access
PDF file
MCMarcin Chyra
Marcin Chyra
MDMagdalena Dudzińska
Magdalena Dudzińska
Marek ManderaMarek Mandera
Marek Mandera
KLKatarzyna Lipka
Katarzyna Lipka
MBMarek Boba
Marek Boba
Porażenie wiotkie kończyn górnych u 6-latka jako manifestacja wyściółczaka anaplastycznego rdzenia kręgowego - Marcin Chyra, Magdalena Dudzińska, Marek Mandera, Katarzyna Lipka, Marek Boba

1 January 2022 in Białorutenistyka Białostocka
Verified
Journal Article
Closed access
PDF file
UBUniwersytet w Białymstoku
Uniwersytet w Białymstoku
MDMagdalena Dudzińska
Magdalena Dudzińska
The article addresses the issue of the Philomath generation from a regional (Podlasie) perspective with reference to the group’s borderland features. In addition to demonstrating the interest of the Philomaths in what is related to the place and its peculiarities (for example, language and history), the “borderland-ness” of the biography of the Podlasie Philomaths and Philarets is evidenced, among other things, by the frequent necessity to move also within the borderlands, resulting from the place of residence, as well as the diversity of the community, often associated with a little-known place translated into limited knowledge of the biographies of subsequent Philomaths – and so borderland-ness is expressed in this case in bringing out of „oblivion” the Philomaths who were less well-known, but associated with the region.